Quest Diagnostics

(DGX) - Get Report

remains comfortable with Wall Street's projections for the first quarter, according to a filing with the

Securities and Exchange Commission

.

"Our outlook remains uncharged from the guidance we offered on our fourth quarter 2000 financial conference call on January 30, 2001," the company said in the filing. Quest said it remains comfortable with the

First Call/Thomson Financial

consensus profit estimate of 63 cents a share for the first quarter.

The filing went on to say that the clinical laboratory testing company also expects earnings for the full year of $3.10 to $3.20 a share. Analysts are projecting earnings of $3.15 for the year. In January, the company reported earnings for the fourth quarter that

exceeded expectations by a penny.

Shares of Quest, which is based in Teterboro, N.J., fell 36 cents, or 0.4%, to $88.54 in recent

New York Stock Exchange

trading.